TMC207TBC1003 - A Study in Healthy Volunteers Investigating the Effect of Single-dose TMC207 on the QT/QTc Interval Under Fed Conditions

NCT01291563 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: Moxifloxacin
DRUG: TMC207
DRUG: TMC207 placebo
DRUG: Moxifloxacin placebo

Sponsor

Tibotec BVBA